Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

HALO Halozyme Therapeutics

Watchlist
51.250
-0.420-0.81%
Trading Session  02/08 11:12 ET
High
51.650
Open
51.460
Turnover
4.06M
Low
51.130
Pre Close
51.670
Volume
78.97K
Market Cap
6.93B
P/E(TTM)
34.63
52wk High
59.460
Shares
135.21M
P/E(Static)
18.70
52wk Low
31.996
Float Cap
6.87B
Bid/Ask %
50.00%
Historical High
59.460
Shs Float
133.98M
Volume Ratio
0.33
Historical Low
1.410
Dividend TTM
--
Div Yield TTM
--
P/B
71.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
1.01%
Avg Price
51.391
Lot Size
1
Float Cap
6.87B
Bid/Ask %
50.00%
Historical High
59.460
Shs Float
133.98M
Volume Ratio
0.33
Historical Low
1.410
Dividend TTM
--
P/B
71.48
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
1.01%
Avg Price
51.391
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. The firm products include rHuPH20, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
CEO: Dr. Helen I. Torley, MB.Ch.B.
Market: NASDAQ
Listing Date: 11/01/2004
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist